AR067396A1 - Compuesto derivado de imidazo(1,2-a)piridin-2-ilmetil piperidina sustituida sal hidrocloruro del mismo uso del compuesto o de la sal hidrocloruro para la preparacion de un medicamento y composiciones farmaceuticas que los comprende - Google Patents
Compuesto derivado de imidazo(1,2-a)piridin-2-ilmetil piperidina sustituida sal hidrocloruro del mismo uso del compuesto o de la sal hidrocloruro para la preparacion de un medicamento y composiciones farmaceuticas que los comprendeInfo
- Publication number
- AR067396A1 AR067396A1 ARP080102851A ARP080102851A AR067396A1 AR 067396 A1 AR067396 A1 AR 067396A1 AR P080102851 A ARP080102851 A AR P080102851A AR P080102851 A ARP080102851 A AR P080102851A AR 067396 A1 AR067396 A1 AR 067396A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- compound
- hydrochloride salt
- disorder
- halo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Compuesto de imidazo[1,2-a]piridin-2-ilmetil piperidina sustituida de formula (1): en la que Ar se selecciona entre el grupo que consiste en las formulas: (2) y (3); donde: R1 es alquilo (C1-4), halo, haloalquilo (C1-4), alcoxi (C1-4), haloalcoxi (C1-4), alquil (C1-4)-O-alquilo (C1-4), CN, NR5R6, donde R5 es H o alquilo (C1-4) y R6 es H o alquilo (C1-4); R2 es alquilo(C1-4), alquenilo(C1-4), HO-alquilo (C1-4), halo, haloalquilo (C1-4), alcoxi (C1-4), haloalcoxi C1-4), alquil (C1-4)-O-alquilo (C1-4), CN, NR7R8, donde R7 es H o alquilo (C1-4) y R8 es H o alquilo (C1-4); R3 es alquilo (C1-4), halo, haloalquilo (C1-4), alcoxi (C1-4), haloalcoxi (C1-4), alquil (C1-4)-O-alquilo (C1-4), CN, NR9R10, donde R9 es H o alquilo (C1-4) y R10 es H o alquilo (C1-4); R3 es alquilo (C1-4), halo, haloalquilo (C1-4), alcoxi (C1-4), haloalcoxi (C1-4), alquil (C1-4)-O-alquilo (C1-4), CN, NR11R12, donde R11 es H o alquilo (C1-4) y R12 es H o alquilo (C1-4); n es 0 n 1; p es 0 o 1; q es 0 o 1; r es 0 n 1; o una sal farmacéuticamente aceptable del mismo. El uso de dicho compuesto o una sal farmacéuticamente aceptable del mismo para a preparacion de un medicamento util para el tratamiento de una enfermedad o trastorno que requiere un antagonista del receptor de oxerina humano, tal como un trastorno del sueno, una depresion o un trastorno del estado de ánimo, un trastorno de ansiedad, un trastorno relacionado con el abuso de sustancias o un trastorno alimentario. Composicion farmacéutica que comprende dicho compuesto.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0712887A GB0712887D0 (en) | 2007-07-03 | 2007-07-03 | Novel compounds |
GB0804317A GB0804317D0 (en) | 2008-03-07 | 2008-03-07 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
AR067396A1 true AR067396A1 (es) | 2009-10-07 |
Family
ID=39789338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080102851A AR067396A1 (es) | 2007-07-03 | 2008-07-01 | Compuesto derivado de imidazo(1,2-a)piridin-2-ilmetil piperidina sustituida sal hidrocloruro del mismo uso del compuesto o de la sal hidrocloruro para la preparacion de un medicamento y composiciones farmaceuticas que los comprende |
Country Status (18)
Country | Link |
---|---|
US (2) | US20090022670A1 (es) |
EP (1) | EP2176258A1 (es) |
JP (1) | JP2010531848A (es) |
KR (1) | KR20100030635A (es) |
CN (1) | CN101796053A (es) |
AR (1) | AR067396A1 (es) |
AU (1) | AU2008270294A1 (es) |
BR (1) | BRPI0812981A2 (es) |
CA (1) | CA2691638A1 (es) |
CL (1) | CL2008001951A1 (es) |
CO (1) | CO6270320A2 (es) |
DO (1) | DOP2009000293A (es) |
EA (1) | EA201070091A1 (es) |
IL (1) | IL202665A0 (es) |
MA (1) | MA31470B1 (es) |
PE (1) | PE20090441A1 (es) |
TW (1) | TW200911242A (es) |
WO (1) | WO2009003993A1 (es) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2693820A1 (en) * | 2007-07-27 | 2009-02-05 | Actelion Pharmaceuticals Ltd | 2-aza-bicyclo[3.3.0]octane derivatives |
JP2010540429A (ja) * | 2007-09-24 | 2010-12-24 | アクテリオン ファーマシューティカルズ リミテッド | オレキシン受容体拮抗薬としてのピロリジン類及びピペリジン類 |
CA2713184A1 (en) * | 2008-02-21 | 2009-08-27 | Actelion Pharmaceuticals Ltd | 2-aza-bicyclo[2.2.1]heptane derivatives |
EP2318367B1 (en) * | 2008-04-30 | 2013-03-20 | Actelion Pharmaceuticals Ltd. | Piperidine and pyrrolidine compounds |
US8093255B2 (en) | 2008-10-09 | 2012-01-10 | Glaxo Group Limited | Imidazo[1,2-A]pyrimidines as orexin receptor antagonists |
US8129384B2 (en) * | 2008-10-09 | 2012-03-06 | Glaxo Group Limited | Imidazo[1,2-a]pyrazines as orexin receptor antagonists |
JP2012509912A (ja) * | 2008-11-26 | 2012-04-26 | グラクソ グループ リミテッド | 新規の化合物 |
JP2012509910A (ja) * | 2008-11-26 | 2012-04-26 | グラクソ グループ リミテッド | 新規の化合物 |
EP2358712A1 (en) * | 2008-11-26 | 2011-08-24 | Glaxo Group Limited | Piperidine derivatives useful as orexin receptor antagonists |
JP2012510493A (ja) | 2008-12-02 | 2012-05-10 | グラクソ グループ リミテッド | N−{[(ir、4s、6r)−3−(2−ピリジニルカルボニル)−3−アザビシクロ[4.1.0]ヘプタ−4−イル]メチル}−2−ヘテロアリールアミン誘導体およびその使用 |
GB0823467D0 (en) * | 2008-12-23 | 2009-01-28 | Glaxo Group Ltd | Novel Compounds |
AU2010240871A1 (en) | 2009-04-24 | 2011-10-27 | Glaxo Group Limited | 3 -azabicyclo [4.1.0] heptanes used as orexin antagonists |
EP2491038B1 (en) | 2009-10-23 | 2016-04-06 | Janssen Pharmaceutica N.V. | Disubstituted octahy - dropyrrolo [3,4-c]pyrroles as orexin receptor modulators |
ES2460915T3 (es) | 2009-12-21 | 2014-05-16 | Novartis Ag | Piridinas fusionadas con heteroarilo disustituido |
WO2011138266A1 (en) * | 2010-05-03 | 2011-11-10 | Evotec Ag | Indolizine and imidazopyridine derivatives as orexin receptor antagonists |
US9242970B2 (en) * | 2010-11-10 | 2016-01-26 | Actelion Pharmaceuticals Ltd. | Lactam derivatives useful as orexin receptor antagonists |
WO2012089607A1 (en) | 2010-12-28 | 2012-07-05 | Glaxo Group Limited | Novel compounds with a 3a-azabicyclo [4.1.0] heptane core acting on orexin receptors |
WO2012089606A1 (en) | 2010-12-28 | 2012-07-05 | Glaxo Group Limited | Azabicyclo [4.1.0] hept - 4 - yl derivatives as human orexin receptor antagonists |
GB201101678D0 (en) | 2011-02-01 | 2011-03-16 | Rolls Royce Plc | A cooling arrangement for a magnetic gearbox |
DK2855453T3 (en) | 2012-06-04 | 2017-02-06 | Actelion Pharmaceuticals Ltd | Benzimidazol-proline derivatives |
SG11201502493XA (en) | 2012-10-10 | 2015-04-29 | Actelion Pharmaceuticals Ltd | Orexin receptor antagonists which are [ortho bi (hetero )aryl]-[2-(meta bi (hetero )aryl)-pyrrolidin-1-yl]-methanone derivatives |
JP2016510810A (ja) | 2013-03-12 | 2016-04-11 | アクテリオン ファーマシューティカルズ リミテッドActelion Pharmaceuticals Ltd | オレキシン受容体アンタゴニストとしてのアゼチジンアミド誘導体 |
GB201318222D0 (en) * | 2013-10-15 | 2013-11-27 | Takeda Pharmaceutical | Novel compounds |
EA030137B1 (ru) | 2013-12-03 | 2018-06-29 | Идорсиа Фармасьютиклз Лтд | Кристаллическая форма (s)-(2-(6-хлор-7-метил-1н-бензо[d]имидазол-2-ил)-2-метилпирролидин-1-ил)(5-метокси-2-(2h-1,2,3-триазол-2-ил)фенил)метанона и ее применение в качестве антагонистов орексинового рецептора |
UA119151C2 (uk) | 2013-12-03 | 2019-05-10 | Ідорсія Фармасьютікалз Лтд | КРИСТАЛІЧНА СОЛЬОВА ФОРМА (S)-(2-(6-ХЛОР-7-МЕТИЛ-1H-БЕНЗО[d]ІМІДАЗОЛ-2-ІЛ)-2-МЕТИЛПІРОЛІДИН-1-ІЛ)(5-МЕТОКСИ-2-(2H-1,2,3-ТРИАЗОЛ-2-ІЛ)ФЕНІЛ)МЕТАНОНУ ЯК АНТАГОНІСТ ОРЕКСИНОВОГО РЕЦЕПТОРА |
MX366642B (es) | 2013-12-04 | 2019-07-17 | Idorsia Pharmaceuticals Ltd | Uso de derivados de bencimidazol-prolina. |
TW201613864A (en) * | 2014-02-20 | 2016-04-16 | Takeda Pharmaceutical | Novel compounds |
SG11201804223TA (en) | 2015-11-23 | 2018-06-28 | Sunshine Lake Pharma Co Ltd | OCTAHYDROPYRROLO [3, 4-c] PYRROLE DERIVATIVES AND USES THEREOF |
MY197558A (en) | 2016-03-10 | 2023-06-23 | Janssen Pharmaceutica Nv | Methods of treating depression using orexin-2 receptor antagonists |
WO2017194548A1 (en) | 2016-05-10 | 2017-11-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of autoimmune inflammatory diseases |
WO2020007964A1 (en) | 2018-07-05 | 2020-01-09 | Idorsia Pharmaceuticals Ltd | 2-(2-azabicyclo[3.1.0]hexan-1-yl)-1h-benzimidazole derivatives |
WO2020099511A1 (en) | 2018-11-14 | 2020-05-22 | Idorsia Pharmaceuticals Ltd | Benzimidazole-2-methyl-morpholine derivatives |
WO2023218023A1 (en) | 2022-05-13 | 2023-11-16 | Idorsia Pharmaceuticals Ltd | Thiazoloaryl-methyl substituted cyclic hydrazine-n-carboxamide derivatives |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0400326A2 (hu) * | 2001-06-28 | 2004-09-28 | Smithkline Beecham P.L.C. | Orexin receptor antagonistákként alkalmazható ciklikus N-(aril-karbonil)-amin-származékok és ezeket tartalmazó gyógyszerkészítmények |
-
2008
- 2008-07-01 US US12/165,894 patent/US20090022670A1/en not_active Abandoned
- 2008-07-01 KR KR1020097027582A patent/KR20100030635A/ko not_active Application Discontinuation
- 2008-07-01 BR BRPI0812981-9A2A patent/BRPI0812981A2/pt not_active IP Right Cessation
- 2008-07-01 JP JP2010513961A patent/JP2010531848A/ja active Pending
- 2008-07-01 WO PCT/EP2008/058423 patent/WO2009003993A1/en active Application Filing
- 2008-07-01 CL CL2008001951A patent/CL2008001951A1/es unknown
- 2008-07-01 PE PE2008001119A patent/PE20090441A1/es not_active Application Discontinuation
- 2008-07-01 TW TW097124654A patent/TW200911242A/zh unknown
- 2008-07-01 AU AU2008270294A patent/AU2008270294A1/en not_active Abandoned
- 2008-07-01 CN CN200880105361A patent/CN101796053A/zh active Pending
- 2008-07-01 US US12/664,945 patent/US20120095034A1/en not_active Abandoned
- 2008-07-01 AR ARP080102851A patent/AR067396A1/es not_active Application Discontinuation
- 2008-07-01 EP EP08785891A patent/EP2176258A1/en not_active Withdrawn
- 2008-07-01 EA EA201070091A patent/EA201070091A1/ru unknown
- 2008-07-01 CA CA002691638A patent/CA2691638A1/en not_active Abandoned
-
2009
- 2009-12-10 IL IL202665A patent/IL202665A0/en unknown
- 2009-12-29 DO DO2009000293A patent/DOP2009000293A/es unknown
- 2009-12-30 CO CO09149373A patent/CO6270320A2/es not_active Application Discontinuation
- 2009-12-30 MA MA32459A patent/MA31470B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI0812981A2 (pt) | 2014-12-16 |
DOP2009000293A (es) | 2010-03-31 |
IL202665A0 (en) | 2010-06-30 |
CA2691638A1 (en) | 2009-01-08 |
EA201070091A1 (ru) | 2010-06-30 |
EP2176258A1 (en) | 2010-04-21 |
PE20090441A1 (es) | 2009-05-08 |
KR20100030635A (ko) | 2010-03-18 |
TW200911242A (en) | 2009-03-16 |
JP2010531848A (ja) | 2010-09-30 |
US20090022670A1 (en) | 2009-01-22 |
MA31470B1 (fr) | 2010-06-01 |
AU2008270294A1 (en) | 2009-01-08 |
CN101796053A (zh) | 2010-08-04 |
WO2009003993A1 (en) | 2009-01-08 |
CL2008001951A1 (es) | 2009-01-09 |
US20120095034A1 (en) | 2012-04-19 |
CO6270320A2 (es) | 2011-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR067396A1 (es) | Compuesto derivado de imidazo(1,2-a)piridin-2-ilmetil piperidina sustituida sal hidrocloruro del mismo uso del compuesto o de la sal hidrocloruro para la preparacion de un medicamento y composiciones farmaceuticas que los comprende | |
AR069772A1 (es) | Derivados heterociclicos, una composicion farmaceutica y un juego que los comprenden y su uso en la preparacion de un medicamento para el tratamiento de una infeccion parasitaria. | |
AR077328A1 (es) | Derivados de oxazina y su uso en el tratamiento de trastornos neurologicos | |
AR061101A1 (es) | Compuesto de fenil-triazolil- metoxi- arilo, su uso para la manufactura de un medicamento y composicion farmaceutica que lo comprende | |
AR062526A1 (es) | DERIVADOS DE 4-(3-METILMORFOLIN-4-IL)PIRIMIDINA Y MORFOLIN-4-IL-PIRIMIDINA COMO INHIBIDORES DE MTOR QUINASA Y PI3K, UNA COMPOSICIoN FARMACEUTICA QUE LOS COMPRENDE Y EL USO DE LOS MISMOS EN LA FABRICACION DE MEDICAMENTOS PARA EL TRATAMIENTO DE DIVERSOS TIPOS DE CANCER. | |
AR037329A1 (es) | Compuestos pirazolo pirimidinona, procedimientos para la preparacion de los mismos, composiciones farmaceuticas de los mismos y usos de los mismos en la preparacion de medicamentos | |
RU2012144317A (ru) | Противоинфекционные соединения | |
AR038240A1 (es) | Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para su preparacion | |
BRPI0509074A (pt) | composições farmacêuticas compreendendo agonistas do receptor da tiróide | |
ECSP056115A (es) | ANTAGONISTAS DEL RECEPTOR A2a DE 2-ALQUINIL- Y 2-ALQUENIL-PIRAZOLO-[4,3-e]-1,2,4-TRIAZOLO-[1,5-c]-PIRIMIDINA ADENOSINA | |
AR047466A1 (es) | Compuestos derivados de 3h - imidazo[4,5 - b]piridina con actividad inhibidora de quinasa, composiciones farmacéuticas que los contienen como principio activo y su uso en la fabricacion de un medicamento para el tratatmiento de neoplasmas susceptibles. | |
AR074238A1 (es) | Compuesto de n-{[(1r,4s,6r)-3-(2-piridinilcarbonil)-3-azabiciclo[4,1.0]hept-4-il]metil}-2-heteroarilamina, su uso para la preparacion de un medicamento util para el tratamiento de una enfermedad que requiere un antagonista del receptor de orexina humano y composicion farmaceutica que lo comprende | |
UY29766A1 (es) | Formas cristalinas delta y épsilon de mesilato de imatinib | |
DE60320012D1 (de) | Aminoheterocyclen als vr-1 antagonisten zur behandlung von schmerzen | |
AR049711A1 (es) | Compuestos heterociclicos condensados como inhibidores de la aldosterona sintasa; composiciones farmaceuticas que los contienen y su uso en la preparacion de un medicamento para el tratamiento o prevencion de enfermedades relacionadas con el hiperaldosterismo y por una liberacion excesiva de cortiso | |
UY29301A1 (es) | Derivados amida | |
RU2011138962A (ru) | Производные 4-изопропилфенилглюцита в качестве ингибиторов sglt1 | |
AR043658A1 (es) | Derivados 8-substituidos-6,7,8,9-tetrahidropirimido[1,2-a]pirimidin-4-ona | |
MY146022A (en) | Substituted acetophenones useful as pde4 inhibitors | |
AR063256A1 (es) | Derivados de 4, 5, 6, 7-tetrahidro-imidazo[4, 5, 1-jk][1]benzacepin-2(1h)-ona, una composicion farmaceutica y un aditivo de pienso que los comprenden y el uso de los mismos como medicamento para el tratamiento de enfermedades mediadas por agonistas del adrenoreceptor beta-2. | |
RU2013136895A (ru) | Новое бициклическое соединение или его соль | |
AR040580A1 (es) | Derivados de pirazol heterobiciclico como inhibidores de la quinasa | |
CY1111707T1 (el) | Παραγωγα toy 1,4 διαζαδικυκλο 3.2.1 οκτανοκαρβοξυαμιδιου, η παρασκευη τους και η θεραπευτικη εφαρμογη τους | |
PA8568101A1 (es) | Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso | |
AR054707A1 (es) | Derivados de octahidropirrolo 3,4-c pirrol, un procedimiento para su preparacion, una composicion farmaceutica y uso del compuesto para la fabricacion de un medicamento |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |